Loomis Sayles & Co. L P Raises Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Loomis Sayles & Co. L P lifted its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 2.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,050,549 shares of the company’s stock after purchasing an additional 28,790 shares during the quarter. Loomis Sayles & Co. L P’s holdings in Option Care Health were worth $24,372,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of the business. Graypoint LLC bought a new position in Option Care Health during the 4th quarter valued at about $1,161,000. Charles Schwab Investment Management Inc. lifted its position in Option Care Health by 6.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company’s stock valued at $58,235,000 after purchasing an additional 147,054 shares during the period. Global Alpha Capital Management Ltd. boosted its holdings in Option Care Health by 38.1% in the fourth quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company’s stock worth $1,596,000 after purchasing an additional 18,992 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new stake in Option Care Health in the 4th quarter worth approximately $327,000. Finally, Barclays PLC raised its stake in Option Care Health by 180.1% during the 3rd quarter. Barclays PLC now owns 310,194 shares of the company’s stock valued at $9,708,000 after buying an additional 199,454 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. UBS Group initiated coverage on Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target on the stock. JMP Securities restated a “market outperform” rating and set a $30.00 price target (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Barrington Research raised their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a report on Thursday, February 27th. Finally, JPMorgan Chase & Co. upped their target price on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a report on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, Option Care Health currently has an average rating of “Moderate Buy” and an average target price of $33.00.

Insider Activity at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares of the company’s stock, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.64% of the stock is owned by corporate insiders.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $34.73 on Friday. The company has a market capitalization of $5.70 billion, a P/E ratio of 29.18, a P/E/G ratio of 2.30 and a beta of 1.33. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The firm’s 50 day simple moving average is $32.47 and its two-hundred day simple moving average is $28.44. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.